New Delhi, April 15 -- In a significant development that underscores closure over prolonged litigation, the Supreme Court has brought the Sterling Biotech matter involving Nitin J. Sandesara and his group to a conclusive end, recording a total recovery of approximately Rs 9,800 crore and directing that all proceedings be finally settled.

The case, which originated from a CBI FIR alleging dues of Rs 5,383 crore, witnessed substantial recoveries over time. The Court noted that Rs 3,507 crore had already been repaid to lending banks, while Rs 1,192 crore was realised through liquidation of assets. In addition, a further deposit of Rs 5,111.43 crore was recorded, significantly contributing to the overall settlement figure.

Taking into accou...